NDC 72677-551

UPLIZNA

Inebilizumab

UPLIZNA is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Viela Bio, Inc.. The primary component is Inebilizumab.

• Product ID: 72677-551_2b9d1b79-50d5-438b-8161-2e3c6722d83a
• NDC: 72677-551
• Product Type: Human Prescription Drug
• Proprietary Name: UPLIZNA
• Generic Name: Inebilizumab
• Dosage Form: Injection
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2020-03-02
• Marketing Category: BLA / BLA
• Application Number: BLA761142
• Labeler Name: Viela Bio, Inc.
• Substance Name: INEBILIZUMAB
• Active Ingredient Strength: 10 mg/mL
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 72677-551-01

3 VIAL, SINGLE-DOSE in 1 CARTON (72677-551-01) > 10 mL in 1 VIAL, SINGLE-DOSE (72677-551-03)

• Marketing Start Date: 2020-06-11
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 72677-551-01 [72677055101]

UPLIZNA INJECTION

• Marketing Category: BLA
• Application Number: BLA761142
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2020-03-02

Drug Details

Active Ingredients

Ingredient	Strength
INEBILIZUMAB	10 mg/mL

NDC Crossover Matching brand name "UPLIZNA" or generic name "Inebilizumab"

NDC	Brand Name	Generic Name
72677-551	UPLIZNA	Inebilizumab
75987-150	UPLIZNA	Inebilizumab